In an endeavour to leverage AI to combat cardiovascular disease, a biggest cause of mortality in India, Apollo Hospitals Group and Microsoft India have joined hands. As per the understanding, a National Clinical Coordination Committee for AI-powered Cardiovascular Disease Risk Score API will be established.
The coordination committee will be assisting the core team at Apollo Hospitals and Microsoft by providing guidance on all cardiology and cardiovascular-related artificial intelligence projects. It will also provide insights on developing clinical algorithm and treatment guidelines based on the inferences of national, multi-centre prospective study, a release said here.
“The NCCC is a great step forward as part of our partnership with Apollo. We are also engaging global consortium partners to scale the AI-powered API (application programme interface),” Microsoft, Cloud & Enterprise, Corporate Vice President, Anil Bhansali said.
“We have already received approval for a pilot study and we hope that the findings will enable physicians to better understand the causes of CVDs in the Indian population,” he added.
According to the release, cardiovascular diseases (CVDs) are responsible for approx 25 per cent mortalities in the age group of 25 to 69 years in India. The condition also seems to affect Indians at least a decade earlier as compared to the Europeans.
Given the high prevalence of CVDs among Indians, Apollo Hospitals and Microsoft India, in 2018, launched the first ever AI-powered CVD Risk Score API, designed specifically to predict the risk of cardiovascular disease in the Indian population, it said.
Speaking about the National Clinical Coordination Committee, Apollo Hospitals Group, Joint Managing Director, Sangita Reddy, said, “The NCCC will help us immensely in our fight against the rising tsunami of Non-Communicable Diseases (NCDs).”